{"text": ["Nucala", "May", "Be", "a", "Game-Changing", "Product", "in", "Respiratory", "Segment"], "created_at": "2018-01-30 23:00:03"}
{"text": ["Here's", "Why", "Momenta", "Pharmaceuticals,", "Inc.", "Jumped", "12%", "Today"], "created_at": "2018-01-30 22:44:57"}
{"text": ["Here's", "Why", "Momenta", "Pharmaceuticals,", "Inc.", "Jumped", "12%", "Today"], "created_at": "2018-01-30 22:44:57"}
{"text": ["An", "In-Depth", "Look", "at", "Array", "BioPharma\u2019s", "Pipeline", "of", "Drugs"], "created_at": "2018-01-30 22:35:02"}
{"text": ["This", "Could", "Significantly", "Drive", "Gilead\u2019s", "Revenue", "Growth", "in", "2018"], "created_at": "2018-01-30 22:29:26"}
{"text": ["Trelegy", "Ellipta", "May", "Emerge", "as", "Major", "Growth", "Driver", "for", "GlaxoSmithKline"], "created_at": "2018-01-30 21:26:49"}
{"text": ["Analyst", "Ratings", "for", "Array", "BioPharma", "and", "Peers", "in", "January", "2018"], "created_at": "2018-01-30 21:03:33"}
{"text": ["Johnson", "&", "Johnson\u2019s", "Growth", "Rate", "for", "4Q17"], "created_at": "2018-01-30 19:20:03"}
{"text": ["Roche", "Gets", "Breakthrough", "Therapy", "Designation", "For", "ASD", "Drug"], "created_at": "2018-01-30 16:48:35"}
{"text": ["Roche", "Gets", "Breakthrough", "Therapy", "Designation", "For", "ASD", "Drug"], "created_at": "2018-01-30 16:48:35"}
{"text": ["3", "Top", "Dividend", "Stocks", "With", "Yields", "Over", "2%"], "created_at": "2018-01-30 16:44:37"}
{"text": ["3", "Top", "Dividend", "Stocks", "With", "Yields", "Over", "2%"], "created_at": "2018-01-30 16:44:37"}
{"text": ["3", "Top", "Dividend", "Stocks", "With", "Yields", "Over", "2%"], "created_at": "2018-01-30 15:34:00"}
{"text": ["The", "Swiss", "Stock", "Market", "Fell", "Further", "Due", "To", "Concerns", "Over", "US", "Bond", "Yields"], "created_at": "2018-01-30 12:30:00"}
{"text": ["The", "Swiss", "Stock", "Market", "Fell", "Further", "Due", "To", "Concerns", "Over", "US", "Bond", "Yields"], "created_at": "2018-01-30 12:30:00"}
